Skip to main content
Clinical Trials/NL-OMON29304
NL-OMON29304
Not yet recruiting
Not Applicable

A retrospective longitudinal clinical cohort study to evaluate HPV testing post-treatment and the long term risk at (cervical) disease

HUMAVAC (VU University Medical Center)0 sites440 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cervical Intraepithelial neoplasia (CIN), Human Papillomavirus (HPV), post-treatment, long term, recurrence, recidive In Dutch: (pre)maligne afwijkingen cervix,CIN, Humaan papillomavirus (HPV), post-treatment, lange termijn, recidief
Sponsor
HUMAVAC (VU University Medical Center)
Enrollment
440
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
HUMAVAC (VU University Medical Center)

Eligibility Criteria

Inclusion Criteria

  • All subjects must satisfy the following criteria at study entry:
  • 1\. Previous participation in one of the following studies: Addition of high\-risk HPV testing improves the current guidelines on follow\-up after treatment for Cervical Intraepithelial Neoplasia”, conducted by Nobbenhuis et al., Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial” conducted by Hogewoning et al., or Post treatment CIN: Randomized Clinical Trial using hrHPV testing for prediction of residual/ recurrent disease ”, conducted by Bais et al.

Exclusion Criteria

  • 1\. Pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials